There are limited data regarding treatment options for pregnant women with severe coronavirus disease 2019 (COVID-19). However, the use of convalescent plasma therapy and remdesivir in was reported to be successful in the management of a critically ill obstetric patient with novel coronavirus 2019 infectio
A novel flu-like coronavirus emerged from Wuhan, China in December 2019. It was named Severe Acute R...
The recent outbreak of the COVID-19 pandemic has caused a re-evaluation of the effectiveness of conv...
As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been re...
Coronavirus disease 2019 (COVID-19) has resulted in an unprecedented global healthcare crisis. One s...
Numerous therapeutic strategies are proposed and tested for SARS CO-V2 infection. Remdesivir is rese...
Introduction: Management of seriously ill patients infected with new corona virus (SARS-CoV-2) is ch...
We are into the second year of the COVID-19 pandemic which is caused by an RNA virus, belonging to t...
The treatment of COVID-19 is particularly critical in pregnant women, considering the potential tera...
The treatment of COVID-19 is particularly critical in pregnant women, considering the potential tera...
Remdesivir is efficacious for severe coronavirus disease 2019 (COVID-19) in adults, but data in preg...
From the beginning of corona virus disease 19(COVID-19) pandemic, there has been concern how to prot...
Pregnancy was reported to be a risk factor for coronavirus disease 2019 (COVID-19), with an increase...
Corona virus 2019 is an emerging disease with a rapid increase in cases and deaths. Limited data is ...
© 2021 BMJ Publishing Group. All rights reserved. Convalescent plasma, which contains antibodies fro...
Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir...
A novel flu-like coronavirus emerged from Wuhan, China in December 2019. It was named Severe Acute R...
The recent outbreak of the COVID-19 pandemic has caused a re-evaluation of the effectiveness of conv...
As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been re...
Coronavirus disease 2019 (COVID-19) has resulted in an unprecedented global healthcare crisis. One s...
Numerous therapeutic strategies are proposed and tested for SARS CO-V2 infection. Remdesivir is rese...
Introduction: Management of seriously ill patients infected with new corona virus (SARS-CoV-2) is ch...
We are into the second year of the COVID-19 pandemic which is caused by an RNA virus, belonging to t...
The treatment of COVID-19 is particularly critical in pregnant women, considering the potential tera...
The treatment of COVID-19 is particularly critical in pregnant women, considering the potential tera...
Remdesivir is efficacious for severe coronavirus disease 2019 (COVID-19) in adults, but data in preg...
From the beginning of corona virus disease 19(COVID-19) pandemic, there has been concern how to prot...
Pregnancy was reported to be a risk factor for coronavirus disease 2019 (COVID-19), with an increase...
Corona virus 2019 is an emerging disease with a rapid increase in cases and deaths. Limited data is ...
© 2021 BMJ Publishing Group. All rights reserved. Convalescent plasma, which contains antibodies fro...
Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir...
A novel flu-like coronavirus emerged from Wuhan, China in December 2019. It was named Severe Acute R...
The recent outbreak of the COVID-19 pandemic has caused a re-evaluation of the effectiveness of conv...
As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been re...